Great News for Vaccine Production in Africa
8/1/2021
After a slow start, vaccination programs in the countries of safari Africa are finally starting to accelerate. Leading the field, South Africa administered roughly 1.2 million doses of Pfizer and J&J vaccine during the week ending July 22nd, nearly three times the number administered during the corresponding week in June - vaccine inventory is finally starting to arrive, and the people are ready for it!
South Africa's rapidly accelerating vaccination program
In a major breakthrough for the continent, the Biovac Institute in Cape Town signed an agreement with Pfizer last week to manufacture their ground-breaking mRNA Covid-19 vaccine, starting in 2022, at an initial capacity of 100 million doses annually. Biovac becomes the second pharmaceutical company in South Africa licensed to produce Covid-19 vaccines, joining Aspen Pharmacare which is already manufacturing the Johnson & Johnson vaccine at a current capacity of 300 million doses per year.